Biodesix Inc BDSX

$27.72 +0.39 (1.43%)

Valuation

Market cap
288,359,000
Revenue TTM
$88,500,000
Net income TTM
$-35,270,000
PE ratio
0.00
Forward PE
—
Profit margin
-39.85%
Debt to equity
5.12

Trading

Volume
124,300
Avg volume
108,146
Day's range
$26.97 – $28.72
Shares out
10,551,000
Stochastic %K
25%
Beta
0.56
Analysts
Strong Sell
Price target
$37.33

Price

Company profile

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR...

Show more

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
303 417 0500
Website
https://www.biodesix.com
Address
919 West Dillon Road, Louisville, United States

Latest news

Stocktwits

LuckyEnzo Oct 2, 3:29 PM
@EquivalentExchange is on an absolute tear recently🔥the plays just keep getting better! If you’re not following yet you’re missing out. $GIBO $QNCX $BDSX sweet
0 replies
healthcareguru Sep 28, 5:41 PM
$BDSX $100 …volume spiking 🔥🦾 $XBI $IWM $XLV
0 replies
healthcareguru Sep 24, 5:25 PM
$BDSX this is going to $100… 🔥🔥 $XBI $IWM $XLV $GRAL
0 replies
focafoca99 Sep 24, 10:22 AM
$BDSX launched two complementary MRD programs with Bio-Rad and Thermo Fisher, expanding its cancer-monitoring portfolio.
0 replies
healthcareguru Sep 24, 12:06 AM
$BDSX this could legit be a $100 stock by YE27…DIRT CHEAP valuation for the premier growth profile, inflecting profitability, solid BS, & M&A optionality. $XLV $XBI $IWM $IBB
0 replies
OpenOutcrier Sep 15, 12:14 PM
$BDSX (+4.4% pre) Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings https://ooc.bz/l/114206
0 replies
LewisDaKat Sep 14, 9:30 PM
$BDSX Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings https://marketwirenews.com/stock/bdsx/news/biodesix-quality-and-regulatory-executive-brianna-ph-6788694101081571.html?utm_source=stocktwits
0 replies
healthcareguru Sep 3, 6:51 PM
$BDSX Buyer daily…this is going to $50. 🦾 $IWM $XLV $XLV
0 replies